⌕
Pulse Biosciences · PLSE · Nasdaq
Tenet 46 · Mixed
Compare
$44.84−3.28%At closeTenet 46 · Mixed
$44.84−1.52 (−3.28%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Pulse Biosciences (PLSE) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

● MarketBeatNov 6, 2026 · 10:15 ET
What Pulse Biosciences (PLSE) Said on Its Q3 Earnings Call

Pulse Biosciences NASDAQ: PLSE said it completed enrollment ahead of schedule in the pivotal U.S. study of its nPulse Cardiac Catheter, setting up a data readout expected in the third quarter of 2027 as the company incre…

● Business WireNov 6, 2026 · 07:00 ETCOMPANY'S OWN WORDS
Pulse Biosciences Presents Six-Month Interim Results from the PRECISE-BTN Multicenter Study at the American Thyroid Association Annual Meeting

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), the company leveraging its ever evolving novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced …

● Seeking AlphaNov 6, 2026 · 06:04 ET
Pulse Biosciences, Inc. (PLSE) Q3 2026 Earnings Call Transcript

Pulse Biosciences, Inc. (PLSE) Q3 2026 Earnings Call Transcript…

● Business WireNov 5, 2026 · 16:05 ETCOMPANY'S OWN WORDS
Pulse Biosciences Reports Business Updates and Third Quarter 2026 Financial Results

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), the company leveraging its ever evolving novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced …

● Business WireOct 29, 2026 · 13:05 ETCOMPANY'S OWN WORDS
Pulse Biosciences to Present at Stifel 2026 Healthcare Conference

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), the company leveraging its ever evolving novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced …

● Business WireOct 22, 2026 · 16:05 ETCOMPANY'S OWN WORDS
Pulse Biosciences Schedules Third Quarter 2026 Financial Results Conference Call for November 5, 2026

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), the company leveraging its ever evolving novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced …

● Defense WorldOct 19, 2026 · 06:14 ET
Varex Imaging (NASDAQ:VREX) vs. Pulse Biosciences (NASDAQ:PLSE) Head to Head Review

Pulse Biosciences (NASDAQ: PLSE - Get Free Report) and Varex Imaging (NASDAQ: VREX - Get Free Report) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the stren…

● Business WireOct 14, 2026 · 07:00 ETCOMPANY'S OWN WORDS
Pulse Biosciences Announces Commercial and Clinical Partnership with the Clayman Thyroid Center

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), the company leveraging its ever evolving novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced …

● Business WireOct 9, 2026 · 16:05 ETCOMPANY'S OWN WORDS
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), the company leveraging its ever evolving novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced …

● Business WireOct 8, 2026 · 07:00 ETCOMPANY'S OWN WORDS
Pulse Biosciences' nPulse™ Technology to be Featured at the 21st Annual International VT Symposium 2026

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), the company leveraging its ever evolving novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced …

● Business WireOct 7, 2026 · 07:00 ETCOMPANY'S OWN WORDS
Pulse Biosciences Achieves Enrollment Target in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation Treatment

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced that its NANOPUL…

● Defense WorldOct 6, 2026 · 06:15 ET
Pulse Biosciences, Inc (NASDAQ:PLSE) Stock Has Average Price Target of $50.20

Shares of Pulse Biosciences, Inc (NASDAQ: PLSE - Get Free Report) have been given a consensus rating of "Moderate Buy" by the seven ratings firms that are covering the firm, Marketbeat Ratings reports. One analyst has ra…

● Business WireSep 15, 2026 · 07:00 ETCOMPANY'S OWN WORDS
Pulse Biosciences Completes Enrollment in the PRECISE-BTN Clinical Study Evaluating the nPulse™ Vybrance™ Percutaneous Electrode System for Symptomatic Benign Thyroid Nodules

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse™ technology using proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced t…

● The Motley FoolSep 9, 2026 · 19:24 ET
Why Pulse Biosciences Stock Popped Today

An analyst initiated coverage with an unambiguous buy recommendation. He feels that one market in particular is ripe for disruption by the company.…

● Business WireSep 4, 2026 · 07:00 ETCOMPANY'S OWN WORDS
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced that the Compens…

● Defense WorldSep 2, 2026 · 04:06 ET
Deutsche Bank AG Takes Position in Pulse Biosciences, Inc $PLSE

Deutsche Bank AG purchased a new stake in Pulse Biosciences, Inc (NASDAQ: PLSE) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 24,786 shares…

● Defense WorldAug 20, 2026 · 03:24 ET
Bank of America Corp DE Grows Stake in Pulse Biosciences, Inc $PLSE

Bank of America Corp DE raised its holdings in shares of Pulse Biosciences, Inc (NASDAQ: PLSE) by 8.2% in a recent quarter, according to the company in its most recent disclosure with the Securities and Exchange Commissi…

● Defense WorldAug 19, 2026 · 04:25 ET
Pulse Biosciences (NASDAQ:PLSE) Sets New 1-Year High – Here’s Why

Pulse Biosciences, Inc (NASDAQ: PLSE - Get Free Report) shares reached a new 52-week high during trading on Wednesday. The stock traded as high as $48.10 and last traded at $46.00, with a volume of 525728 shares trading …

● Business WireAug 18, 2026 · 07:00 ET
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced that the Compens…

Kept in their own lane. A press release is the company talking, not reporting.

No upcoming events in the feeds.

Article counts from the last market-wide feed page, across every symbol we track and not just PLSE · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.